Landowski Michael, Gogoi Purnima, Ikeda Sakae, Ikeda Akihiro
Department of Medical Genetics, University of Wisconsin-Madison, Madison, WI, United States.
McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, United States.
Front Ophthalmol (Lausanne). 2024;4. doi: 10.3389/fopht.2024.1355379. Epub 2024 Jan 31.
Aging is the most significant risk factor for age-related diseases in general, which is true for age-related diseases in the eye including age-related macular degeneration (AMD). Therefore, in order to identify potential therapeutic targets for these diseases, it is crucial to understand the normal aging process and how its mis-regulation could cause age-related diseases at the molecular level. Recently, abnormal lipid metabolism has emerged as one major aspect of age-related symptoms in the retina. Animal models provide excellent means to identify and study factors that regulate lipid metabolism in relation to age-related symptoms. Central to this review is the role of transmembrane protein 135 (TMEM135) in the retina. TMEM135 was identified through the characterization of a mutant mouse strain exhibiting accelerated retinal aging and positional cloning of the responsible mutation within the gene, indicating the crucial role of TMEM135 in regulating the normal aging process in the retina. Over the past decade, the molecular functions of TMEM135 have been explored in various models and tissues, providing insights into the regulation of metabolism, particularly lipid metabolism, through its action in multiple organelles. Studies indicated that TMEM135 is a significant regulator of peroxisomes, mitochondria, and their interaction. Here, we provide an overview of the molecular functions of TMEM135 which is crucial for regulating mitochondria, peroxisomes, and lipids. The review also discusses the age-dependent phenotypes in mice with TMEM135 perturbations, emphasizing the importance of a balanced TMEM135 function for the health of the retina and other tissues including the heart, liver, and adipose tissue. Finally, we explore the potential roles of TMEM135 in human age-related retinal diseases, connecting its functions to the pathobiology of AMD.
总体而言,衰老是与年龄相关疾病的最重要风险因素,眼部与年龄相关的疾病包括年龄相关性黄斑变性(AMD)亦是如此。因此,为了确定这些疾病的潜在治疗靶点,了解正常衰老过程以及其失调如何在分子水平上导致与年龄相关的疾病至关重要。最近,异常脂质代谢已成为视网膜与年龄相关症状的一个主要方面。动物模型为识别和研究与年龄相关症状相关的调节脂质代谢的因素提供了极佳手段。本综述的核心是跨膜蛋白135(TMEM135)在视网膜中的作用。通过对一种表现出加速视网膜衰老的突变小鼠品系的特征分析以及对该基因内致病突变的定位克隆,确定了TMEM135,这表明TMEM135在调节视网膜正常衰老过程中起关键作用。在过去十年中,已在各种模型和组织中探索了TMEM135的分子功能,通过其在多个细胞器中的作用,深入了解了代谢调节,特别是脂质代谢。研究表明,TMEM135是过氧化物酶体、线粒体及其相互作用的重要调节因子。在此,我们概述了TMEM135的分子功能,其对调节线粒体、过氧化物酶体和脂质至关重要。本综述还讨论了TMEM135功能紊乱的小鼠的年龄依赖性表型,强调了平衡的TMEM135功能对视网膜以及包括心脏、肝脏和脂肪组织在内的其他组织健康的重要性。最后,我们探讨了TMEM135在人类年龄相关性视网膜疾病中的潜在作用,将其功能与AMD的病理生物学联系起来。